BR112014010169A2 - derivado n-tienilbenzamida substituída com aminoalquil - Google Patents
derivado n-tienilbenzamida substituída com aminoalquilInfo
- Publication number
- BR112014010169A2 BR112014010169A2 BR112014010169A BR112014010169A BR112014010169A2 BR 112014010169 A2 BR112014010169 A2 BR 112014010169A2 BR 112014010169 A BR112014010169 A BR 112014010169A BR 112014010169 A BR112014010169 A BR 112014010169A BR 112014010169 A2 BR112014010169 A2 BR 112014010169A2
- Authority
- BR
- Brazil
- Prior art keywords
- aminoalkyl
- substituted
- thienylbenzamide
- derivative
- thienylbenzamide derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C07D333/80—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
- C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011236533 | 2011-10-27 | ||
| JP2011-236533 | 2011-10-27 | ||
| PCT/JP2012/077660 WO2013062065A1 (ja) | 2011-10-27 | 2012-10-25 | アミノアルキル置換n-チエニルベンズアミド誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014010169A2 true BR112014010169A2 (pt) | 2017-04-25 |
| BR112014010169B1 BR112014010169B1 (pt) | 2021-12-07 |
Family
ID=48167891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014010169-8A BR112014010169B1 (pt) | 2011-10-27 | 2012-10-25 | Compostos de derivado n-tienilbenzamida substituída com aminoalquil, composição contendo os ditos compostos e uso dos mesmos para prevenir ou tratar hiperfosfatemia |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9062032B2 (pt) |
| EP (1) | EP2772490B1 (pt) |
| JP (2) | JP2013107880A (pt) |
| KR (1) | KR101941048B1 (pt) |
| CN (1) | CN103906741B (pt) |
| AR (1) | AR088563A1 (pt) |
| AU (1) | AU2012329913A1 (pt) |
| BR (1) | BR112014010169B1 (pt) |
| CA (1) | CA2853688C (pt) |
| EA (1) | EA023955B1 (pt) |
| ES (1) | ES2585415T3 (pt) |
| IL (1) | IL232230A0 (pt) |
| IN (1) | IN2014CN03130A (pt) |
| MX (1) | MX342521B (pt) |
| PL (1) | PL2772490T3 (pt) |
| TW (1) | TW201323419A (pt) |
| WO (1) | WO2013062065A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2885969C (en) * | 2012-10-02 | 2021-04-06 | Epitherapeutics Aps | Substitued pyridine derivatives and compositions thereof useful as inhibitors of histone demethylases |
| US9499553B2 (en) | 2013-03-13 | 2016-11-22 | Chugai Seiyaku Kabushiki Kaisha | Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same |
| UA118755C2 (uk) | 2013-03-13 | 2019-03-11 | Чугаі Сейяку Кабусікі Кайся | Похідне дигідропіридазин-3,5-діону |
| TWI594975B (zh) | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
| PT3030568T (pt) | 2013-08-08 | 2018-12-24 | Galapagos Nv | Tieno[2,3-c]piranos como moduladores de cftr |
| WO2015064532A1 (ja) * | 2013-10-30 | 2015-05-07 | 第一三共株式会社 | モルホリン化合物 |
| EP3126345A1 (en) * | 2014-03-31 | 2017-02-08 | Gilead Sciences, Inc. | Inhibitors of histone demethylases |
| CN105658635B (zh) * | 2014-08-22 | 2019-03-08 | 江苏恒瑞医药股份有限公司 | 噻吩并环烷基或噻吩并杂环基类衍生物、其制备方法及其在医药上的应用 |
| AU2015316425B2 (en) * | 2014-09-12 | 2019-11-21 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical containing sodium-dependent phosphate transporter inhibitor |
| BR112017005694A2 (pt) | 2014-09-26 | 2017-12-12 | Daiichi Sankyo Co Ltd | cristais de um sal, ou hidrato do mesmo, cristais de um trihidrato de sal dissódico, composição farmacêutica, uso dos cristais, e, método para prevenção ou tratamento de hiperfosfatemia. |
| CN105524053B (zh) * | 2014-10-19 | 2020-06-05 | 广东东阳光药业有限公司 | 四氢苯并噻吩化合物 |
| TW201700458A (zh) | 2015-04-24 | 2017-01-01 | 第一三共股份有限公司 | 二羧酸化合物之製法 |
| CN107082773B (zh) * | 2016-02-16 | 2020-07-28 | 江苏恒瑞医药股份有限公司 | 一种肠2b型磷酸钠协同转运蛋白抑制剂的硫酸盐及其结晶形式 |
| RS61165B1 (sr) * | 2016-08-15 | 2021-01-29 | Lilly Co Eli | Kondenzovani derivati tiofena korisni kao napi-iib inhibitori |
| JOP20190080A1 (ar) | 2016-10-14 | 2019-04-11 | Bayer Pharma AG | مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها |
| CN109422723B (zh) * | 2017-08-25 | 2021-02-23 | 江苏恒瑞医药股份有限公司 | 一种肠2b型磷酸钠协同转运蛋白抑制剂的晶型及其制备方法 |
| AR126060A1 (es) | 2021-06-08 | 2023-09-06 | Chugai Pharmaceutical Co Ltd | Método para producir derivado de dihidropiridazin-3,5-diona |
| WO2022260064A1 (ja) | 2021-06-08 | 2022-12-15 | 中外製薬株式会社 | ジヒドロピリダジン－３，５－ジオン誘導体を含有する製剤 |
| WO2023203254A2 (en) | 2022-04-22 | 2023-10-26 | Fundamental Pharma Gmbh | Effective means to modulate nmda receptor-mediated toxicity |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002028353A2 (en) | 2000-10-05 | 2002-04-11 | Smithkline Beecham Corporation | Phosphate transport inhibitors |
| JP2007131532A (ja) | 2001-09-28 | 2007-05-31 | Kirin Brewery Co Ltd | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 |
| WO2003048134A1 (fr) | 2001-12-05 | 2003-06-12 | Japan Tobacco Inc. | Compose de triazole et son utilisation therapeutique |
| US8134015B2 (en) | 2003-03-27 | 2012-03-13 | Kyowa Hakko Kirin Co., Ltd. | Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| WO2006093518A2 (en) | 2004-06-25 | 2006-09-08 | Apath, Llc | Thienyl compounds for treating virus-related conditions |
| CA2579089A1 (en) | 2004-08-30 | 2006-03-09 | Government Of The United States Of America As Represented By The Secreta Ry Department Of Health And Human Services | Inhibition of viruses using rnase h inhibitors |
| EP1802634A2 (en) | 2004-10-20 | 2007-07-04 | Compass Pharmaceuticals LLC | Thiophens and their use as anti-tumor agents |
| JP5236748B2 (ja) * | 2008-01-08 | 2013-07-17 | パーデュー、ファーマ、リミテッド、パートナーシップ | 疼痛治療のためのカンナビノイド受容体のリガンドとしてのプロリン類似体 |
| PL2565190T3 (pl) | 2010-04-28 | 2015-10-30 | Astellas Pharma Inc | Związek tetrahydrobenzotiofenowy |
| ES2547890T3 (es) | 2010-07-07 | 2015-10-09 | Ardelyx, Inc. | Compuestos y métodos para inhibir el transporte de fosfato |
| EP2590965B1 (en) | 2010-07-07 | 2016-04-20 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| WO2012054110A2 (en) | 2010-07-07 | 2012-04-26 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| JP5827328B2 (ja) | 2010-07-07 | 2015-12-02 | アーデリクス，インコーポレーテッド | リン酸輸送を阻害する化合物及び方法 |
| EP2591354B1 (en) | 2010-07-07 | 2016-09-07 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
-
2012
- 2012-10-25 TW TW101139423A patent/TW201323419A/zh unknown
- 2012-10-25 AU AU2012329913A patent/AU2012329913A1/en not_active Abandoned
- 2012-10-25 EP EP12844048.4A patent/EP2772490B1/en active Active
- 2012-10-25 EA EA201490875A patent/EA023955B1/ru not_active IP Right Cessation
- 2012-10-25 CA CA2853688A patent/CA2853688C/en active Active
- 2012-10-25 IN IN3130CHN2014 patent/IN2014CN03130A/en unknown
- 2012-10-25 MX MX2014005090A patent/MX342521B/es active IP Right Grant
- 2012-10-25 ES ES12844048.4T patent/ES2585415T3/es active Active
- 2012-10-25 KR KR1020147014256A patent/KR101941048B1/ko active IP Right Grant
- 2012-10-25 WO PCT/JP2012/077660 patent/WO2013062065A1/ja active Application Filing
- 2012-10-25 CN CN201280053147.6A patent/CN103906741B/zh active Active
- 2012-10-25 US US14/354,086 patent/US9062032B2/en active Active
- 2012-10-25 JP JP2012236135A patent/JP2013107880A/ja active Pending
- 2012-10-25 PL PL12844048.4T patent/PL2772490T3/pl unknown
- 2012-10-25 JP JP2013540835A patent/JP6020460B2/ja active Active
- 2012-10-25 BR BR112014010169-8A patent/BR112014010169B1/pt not_active IP Right Cessation
- 2012-10-26 AR ARP120104035A patent/AR088563A1/es unknown
-
2014
- 2014-04-24 IL IL232230A patent/IL232230A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2014CN03130A (pt) | 2015-07-03 |
| AU2012329913A1 (en) | 2014-05-22 |
| KR101941048B1 (ko) | 2019-01-22 |
| PL2772490T3 (pl) | 2016-11-30 |
| CN103906741A (zh) | 2014-07-02 |
| US20150031727A1 (en) | 2015-01-29 |
| TW201323419A (zh) | 2013-06-16 |
| EP2772490B1 (en) | 2016-04-06 |
| JP6020460B2 (ja) | 2016-11-02 |
| IL232230A0 (en) | 2014-06-30 |
| EP2772490A4 (en) | 2015-01-21 |
| CA2853688C (en) | 2018-06-12 |
| MX342521B (es) | 2016-10-03 |
| BR112014010169B1 (pt) | 2021-12-07 |
| EA023955B1 (ru) | 2016-07-29 |
| KR20140096322A (ko) | 2014-08-05 |
| ES2585415T3 (es) | 2016-10-05 |
| JP2013107880A (ja) | 2013-06-06 |
| CN103906741B (zh) | 2016-01-20 |
| CA2853688A1 (en) | 2013-05-02 |
| EA201490875A1 (ru) | 2014-09-30 |
| US9062032B2 (en) | 2015-06-23 |
| EP2772490A1 (en) | 2014-09-03 |
| AR088563A1 (es) | 2014-06-18 |
| JPWO2013062065A1 (ja) | 2015-04-02 |
| WO2013062065A1 (ja) | 2013-05-02 |
| MX2014005090A (es) | 2015-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014010169A2 (pt) | derivado n-tienilbenzamida substituída com aminoalquil | |
| DK2744810T4 (da) | Tenofovir-alafenamid-hemifumarat | |
| DK2769050T3 (da) | Propsensor | |
| BR112014000879A2 (pt) | deflegmador | |
| DK3272861T3 (da) | Alpha-galactosidase-sammensætninger | |
| CO6960543A2 (es) | 2-tiopirimidinonas | |
| DE102011100082A8 (de) | Traygreifvorrichtung | |
| CO6960557A2 (es) | Derivados de 2-yodo-imidazol | |
| DK3141251T3 (da) | Koloskopi - forberedelse | |
| FI20116167L (fi) | Järjestely | |
| BR112014007790A2 (pt) | derivado de fenila | |
| DE112011104936A5 (de) | Stanzstauchniet | |
| DE112012000958A5 (de) | Handsäge | |
| DK2476953T3 (da) | Fluidbedkedel | |
| CO6852074A2 (es) | Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida | |
| DE112012002458A5 (de) | Hydrotransformator | |
| DE112012000819A5 (de) | Gurtbandfänger | |
| DE112012005313A5 (de) | Leuchtbild | |
| DK2526750T3 (da) | Høbjærgningsmaskine | |
| DE102011117169A8 (de) | Absetzplattenanordnung | |
| FIU20114048U0 (fi) | Järjestely tilan muuttamiseksi | |
| DK2681057T3 (da) | Nanofiber-mærkning | |
| ES1076319Y (es) | Minisalvavidas acuatico | |
| ES1075696Y (es) | Calzoncillo | |
| ES1075978Y (es) | Cucharon-colador-trasvasador |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/10/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2745 DE 15-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |